Ready-to-use capacities for manufacturing Low Volume High Value items have been designed and provided. This includes products such as Buprenorphine,
Naloxone, Naltrexone,Noroxymorphone, Cyproterone Acetate.
The existing production capacities in Tehran and Mashhad sites enable TEMAD Co. to manufacture pharmaceuticals in bulk scale (more than 1300 MT/year).
Depending on the API requirements, TEMAD Co. the capacity can be further increased to 1500 MT.
Supported by decades of valuable experience, TEMAD Co. holds the first position in performing Grignard Reactions with a wide range of complicated Grignard reagents.
This hazardous synthetic step can be conducted in pilot and industrial scale. The Company’s skilled experts have overcome all embedded risks including the
possibility of explosion,flammability unreacted material, work up, etc.)
TEMAD Co. possesses the ability to perform hydrogenation or reduction reactions in 1 gram to 100 kilograms scales. Owing to the availability of know-how of recovery and recycling high-priced catalysts (e.g. Palladium), TEMAD Co. is in a position to offer the above scientific services in most of these reactions.
The Company utilizes Analytical Chemistry experts and various analytical equipment including HPLC, GC, FTIR, XRD, NMR 500 Hz,
Mass Spectrometry, Preparative HPLC, Reverse Phase, and Column Chromatography for:
1) Method of Analysis development
3) separation of active ingredients and impurities to conduct precise analyses according to latest British, European, and US Pharmacopeias
4) preparation of Working Standards of active pharmaceutical ingredients (API) along with scientific documentation
5) DMF and CET preparation based on the latest regulations of Ministry of Health and Medical Education and international organizations
Page 1 of 2